Hofseth BioCare Overview

  • Founded
  • 2000
  • Status
  • Public
  • Employees
  • 51
  • Stock Symbol
  • HBC
Stock Symbol
  • Share Price
  • $1.05
  • (As of Wednesday Closing)

Hofseth BioCare General Information


Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • Havnegata 11
  • 6005 Alesund
  • Norway
+47 73 00 00 00

Hofseth BioCare Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hofseth BioCare Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.05 $0.97 $0.48 - $1.14 $377M 358M 171K -$0.03

Hofseth BioCare Financials Summary

In Thousands,
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 318,643 335,540 80,906 50,775
Revenue 6,049 7,699 7,459 14,327
EBITDA (7,505) (6,100) (7,210) 1,020
Net Income (11,019) (10,134) (10,409) (1,992)
Total Assets 31,160 33,223 21,572 22,437
Total Debt 15,120 15,357 6,907 9,916
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hofseth BioCare Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hofseth BioCare‘s full profile, request access.

Request a free trial

Hofseth BioCare Executive Team (7)

Name Title Board Seat Contact Info
Roger Hofseth Founder and Chief Executive Officer
Jon Ødegård Chief Financial Officer
Karl Slotsvik Chief Operating Officer
Bomi Framroze Chief Scientific Officer
James Berger Head of Investor Relations and Strategy
You’re viewing 5 of 7 executive team members. Get the full list »

Hofseth BioCare Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hofseth BioCare Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hofseth BioCare‘s full profile, request access.

Request a free trial